Antiplatelets
Primary and Secondary stroke prevention; duel therapy not for longterm due to risk of bleeding
Aspirin
Primary prevention; Cyclooxygenase inhibitor; dose 81-325; irreversible, inhibits for the life of platelet (5-7 days)—–common risk=GI bleed—avoid NSAIDs
Aggrenox (Dipyridamole/aspirin)
Secondary prevention;PCE inhibitor; dose: 200/25mg BID; irreversible (5-7days); poorly tolerated–causes headache in 40%
Clopidogrel (Plavix)
secondary prevention; Adenosine diphosphate inhibitor; dose: 75mg daily; PPI decrease plavix effects;
Ticlopidine (Ticlid)
secondary prevention; 250 mg BID; irreversible, last 5-7 days; GI intolerance, neutropenia, aplastic anemia